A phase II study of lapatinib monotherapy in chemotherapy-refractory HER2-positive and HER2-negative advanced or metastatic breast cancer

2008205 citationsJournal Article

Authors

Good health and well-being

Published in: Annals of Oncology

Volume 19, Issue 6, pp. 1068-1074

Field-Weighted Citation Impact: 13.76